CClinicalTrials.gg
Sign In
Status unknownNCT01650116Updated Nov 20, 2014

Evaluation of Hemodynamics and Amount of Blood Flowing Through the Kidneys During Liver Transplant by Measuring Some Physiological Substances in Blood and Urines

An observational study in Hypovolemia During Liver Transplantation and Renal Hypoperfusion During Liver Transplantation, sponsored by Azienda Ospedaliera di Padova. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2014-11-20.

Sponsored by Azienda Ospedaliera di Padova · Observational

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to verify any existing relationship between urinary parameters (such as excretion of sodium, chlorine, urinary partial CO2 pressure [PuCO2]) and general volemic indicators (such as PiCCO, ScvO2, O2 delivery) during liver transplant.

02

Conditions studied

  • Hypovolemia During Liver Transplantation
  • Renal Hypoperfusion During Liver Transplantation

Browse trials for

Keywords

  • hypovolemia
  • renal hypoperfusion
  • liver transplantation
  • sodium
  • chloride
  • PuCO2
  • ScvO2
  • PiCCO
  • O2-delivery
  • hemodynamic indexes
03

In context

Hypovolemia

133 studies on the registry are indexed under Hypovolemia; 19 are open to participants now.

This study's planned enrollment of 50 is close to the median of 52 across 63 observational studies indexed under Hypovolemia.

Browse Hypovolemia studies →

Lead sponsor

Azienda Ospedaliera di Padova is the lead sponsor of 36 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing liver transplantation

Inclusion criteria

  • surgery for liver transplantation
  • age 18-75
  • ASA class I-III

Exclusion criteria

Exclusion Criteria:

  • age above 75 or under 18
  • ASA class IV
  • pre-existing renal failure
  • pregnant patients
  • patients unable to give written consent
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Determination of hemodynamic indicators (PiCCO, ScvO2, O2-delivery) and three urinary analytes (sodium, chloride, CO2 partial pressure)

    Time frame: During the stay of the patient in the operating room (in average 8 hours) and the subsequent stay in the post-surgery intensive care unit (in average 5 days)

07

Study locations

1 of 1 sites recruiting
  • Azienda Ospedaliera di Padova
    Padova, 35128, Italy
    • · Contact · +390498218285
    • · Contact · +390498218286
    • Paolo Feltracco, M.D. · Principal investigator
    • Andrea Bortolato, M.D. · Principal investigator
    • Daniele Bonvicini, M.D. · Sub investigator
    • Tommaso Tonetti, M.D. · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01650116
Lead sponsor
Azienda Ospedaliera di Padova
Responsible party
Dr. Paolo Feltracco (Principal Investigator, Azienda Ospedaliera di Padova) — Principal investigator
First posted
Jul 26, 2012
Start date
Jul 2012
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Nov 20, 2014

Study contacts

Paolo Feltracco, M.D.
Contact
paolofeltracco@inwind.it
+393493410225
Andrea Bortolato, M.D.
Contact
freeandrea.b@libero.it
+393316169933
Carlo Ori, Prof. M.D.
study chair · Università degli Studi di Padova - Azienda Ospedaliera di Padova
Paolo Feltracco, M.D.
principal investigator · Azienda Ospedaliera di Padova
Andrea Bortolato, M.D.
principal investigator · Azienda Ospedaliera di Padova

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypovolemia→

Other studies from this sponsor

Azienda Ospedaliera di Padova

Start the discussion